cancer talk

Survival statistics are important—and sometimes confusing. Cancer Today spoke with statistics experts about what these numbers really mean.

by Ashley P. Taylor

Scientists and physicians discussed advances in targeted therapies and immunotherapies, as well as the lessons COVID-19 research has taught to cancer researchers.

by Kevin McLaughlin

Researchers are studying the effectiveness of drugs for treating COVID-19 in cancer patients who have been infected with the coronavirus.

by Marcus A. Banks

Two immune checkpoint inhibitors are now approved for treatment of some people with advanced breast cancer, but trial results have raised some questions.

by Anna Goshua

Judy Pearson was surprised by the demands of cancer survivorship. Here, she offers tips on how to look at life after cancer.

by Judy Pearson

Keeping her grandfather’s cancer a secret from him felt counterintuitive to Tina Chai as a teen, but conversations with other Chinese Americans helped her understand the reasons Chinese physicians and families may practice cancer nondisclosure.

by Tina Chai

Amid continued research showing the impact of COVID-19 on people with cancer, patients are asking when they should get a COVID-19 vaccine.

by Marci A. Landsmann

Stool-based tests could increase access to colorectal cancer screening.

by Jen Tota McGivney

For adolescents and young adults who have been diagnosed with cancer, caregivers can play an influential—but often overlooked—role in providing help and support.

by Carly Flumer

The Cancer Today editorial staff selects some of the most impactful reporting and essays of 2020.

by Cancer Today Staff